Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jan

Showing results (241-250 of 255) with videos related to

Pageof 26
Sort By:
Annals of Surgical Oncology|July 27, 2024
Interval Metastases After Neoadjuvant Chemoradiotherapy for Patients with Locally Advanced Esophageal Cancer: A Multicenter Observational Cohort StudyCharlène J van der Zijden, Pieter C van der Sluis, Bianca Mostert, et al.
Annals of Surgery|May 25, 2026
Pathological Outcomes After Uncertain Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerSanjiv S G Gangaram Panday, Dion In 't Veld, Bianca Mostert, et al.
BMC Cancer|February 8, 2018
Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trialBo Jan Noordman, Bas P L Wijnhoven, Sjoerd M Lagarde, et al.
Annals of Surgery|October 9, 2019
Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched StudyBerend J van der Wilk, Bo J Noordman, Lisanne K A Neijenhuis, et al.
Trials|May 18, 2021
Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancerBen M Eyck, Berend J van der Wilk, Bo Jan Noordman, et al.
The Lancet. Oncology|March 20, 2025
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trialBerend J van der Wilk, Ben M Eyck, Bas P L Wijnhoven, et al.
The Lancet. Oncology|August 10, 2015
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialJoel Shapiro, J Jan B van Lanschot, Maarten C C M Hulshof, et al.
Annals of Surgery|November 8, 2014
Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survivalA Koen Talsma, Joel Shapiro, Caspar W N Looman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS TrialBen M Eyck, J Jan B van Lanschot, Maarten C C M Hulshof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2017
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS TrialBo Jan Noordman, Mathilde G E Verdam, Sjoerd M Lagarde, et al.
Pageof 26

Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
Annals of Surgical Oncology|July 27, 2024
Interval Metastases After Neoadjuvant Chemoradiotherapy for Patients with Locally Advanced Esophageal Cancer: A Multicenter Observational Cohort StudyCharlène J van der Zijden, Pieter C van der Sluis, Bianca Mostert, et al.
Annals of Surgery|May 25, 2026
Pathological Outcomes After Uncertain Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerSanjiv S G Gangaram Panday, Dion In 't Veld, Bianca Mostert, et al.
BMC Cancer|February 8, 2018
Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trialBo Jan Noordman, Bas P L Wijnhoven, Sjoerd M Lagarde, et al.
Annals of Surgery|October 9, 2019
Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched StudyBerend J van der Wilk, Bo J Noordman, Lisanne K A Neijenhuis, et al.
Trials|May 18, 2021
Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancerBen M Eyck, Berend J van der Wilk, Bo Jan Noordman, et al.
The Lancet. Oncology|March 20, 2025
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trialBerend J van der Wilk, Ben M Eyck, Bas P L Wijnhoven, et al.
The Lancet. Oncology|August 10, 2015
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialJoel Shapiro, J Jan B van Lanschot, Maarten C C M Hulshof, et al.
Annals of Surgery|November 8, 2014
Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survivalA Koen Talsma, Joel Shapiro, Caspar W N Looman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS TrialBen M Eyck, J Jan B van Lanschot, Maarten C C M Hulshof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2017
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS TrialBo Jan Noordman, Mathilde G E Verdam, Sjoerd M Lagarde, et al.
Pageof 26